How should a patient with a serum ammonia level of 366 µmol/L be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Serum Ammonia 366 µmol/L

A patient with ammonia 366 µmol/L requires immediate initiation of continuous kidney replacement therapy (CKRT), specifically high-dose continuous venovenous hemodialysis (CVVHD), alongside aggressive medical management with nitrogen-scavenging agents, as this level falls within the critical range where rapid ammonia removal is essential to prevent irreversible neurological damage. 1

Immediate Assessment and Stabilization

Critical First Steps

  • Stop all protein intake immediately and monitor ammonia every 3 hours 1
  • Assess neurological status urgently - look for:
    • Level of consciousness (lethargy, stupor, coma)
    • Signs of encephalopathy (confusion, disorientation, abnormal movements)
    • Evidence of cerebral edema (altered pupils, posturing, respiratory pattern changes)
    • Seizure activity 1

Diagnostic Workup

While initiating treatment, obtain:

  • Venous blood sample on ice, processed within 15 minutes to confirm ammonia level 2
  • Basic metabolic panel, liver function tests
  • Blood gas (respiratory alkalosis is common) 3
  • Consider urea cycle disorder workup if no obvious liver disease 4, 5

Important caveat: A normal ammonia level essentially rules out hepatic encephalopathy, but your level of 366 µmol/L is definitively elevated and dangerous 6, 2.

Medical Management (Start Immediately)

Metabolic Support

  • Intravenous glucose: 8-10 mg/kg/min to prevent catabolism 1
  • Intravenous lipids: 0.5 g/kg daily, up to 3 g/kg daily 1
  • Total calories: ≥100 kcal/kg daily 1
  • Protein reintroduction: Only after ammonia <100 µmol/L, then gradually at 0.25 g/kg daily increments 1

Nitrogen-Scavenging Agents (Dosing by Weight)

For patients <20 kg:

  • Sodium benzoate: 250 mg/kg IV over 90 minutes, then continuous infusion over 24 hours
  • Sodium phenylacetate: 250 mg/kg IV over 90 minutes, then continuous infusion over 24 hours
  • L-arginine hydrochloride: 200 mg/kg for OTC/CPS deficiency OR 600 mg/kg for ASS/ASL deficiency, over 90 minutes then maintenance 1

For patients >20 kg:

  • Sodium benzoate: 5.5 g/m² IV
  • Sodium phenylacetate: 5.5 g/m² IV
  • L-arginine: 4 g/m² for OTC/CPS OR 12 g/m² for ASS/ASL 1

Critical warning: Maximum sodium benzoate dose is 12 g daily - high doses can be lethal within 1 hour 1. Monitor for hypotension with arginine administration 1.

Kidney Replacement Therapy - The Definitive Intervention

Why CKRT is Indicated at 366 µmol/L

Your patient's ammonia level of 366 µmol/L meets multiple criteria for urgent dialysis 1:

  • Falls within the range requiring rapid ammonia clearance (>300 µmol/L with rapid rise) 1
  • Approaches the threshold for persistently high levels (>400 µmol/L) 1
  • At significant risk for cerebral edema (risk >55% when ammonia >200 µmol/L) 5

The evidence strongly supports that ammonia levels ≥360 µmol/L (600 µg/dL) cause significant brain damage, making this a medical emergency 4.

CKRT Prescription (First-Line Therapy)

High-dose CVVHD is the recommended modality 1:

  • Blood flow rate (Qb): 30-50 ml/min
  • Dialysate flow rate (Qd): Aim for Qd/Qb ratio >1.5
  • Target dialysate flow >1,000 ml/h if equipment allows 1
  • Use warmed dialysate to maintain hemodynamic stability 1

Expected outcomes: Ammonia should decrease to <400 µmol/L within 2-3 hours and to <200 µmol/L within 7-10 hours based on case reports 1, 7.

Alternative: Intermittent Hemodialysis

If CKRT unavailable or for more rapid clearance:

  • Intermittent HD can reduce ammonia by 75% within 3-4 hours 1
  • However, carries higher risk of rebound hyperammonemia 1
  • Consider hybrid approach: HD first for rapid reduction, then transition to CKRT 1

When to Step Down CKRT

Continue CKRT until ammonia <200 µmol/L on two consecutive hourly measurements, then transition to nitrogen-scavenging agents alone 1, 4.

Critical Prognostic Factors

Time is brain - the most important prognostic factor is duration of hyperammonemic coma before dialysis initiation 1:

  • Coma >3 days: poor neurological outcome 1
  • Ammonia >1,000 µmol/L: adverse prognostic factor 1
  • Peak ammonia ≥600 µmol/L (360 µmol/L): threshold for significant brain damage 4

Your patient at 366 µmol/L is at the critical threshold where every hour of delay increases risk of permanent neurological injury.

Special Considerations

If Hemodynamically Unstable

Consider CKRT combined with ECMO, particularly in neonates or small patients with poor vascular access 1. This provides:

  • Increased blood volume
  • Larger cannula capability
  • Better hemodynamic control
  • Rapid ammonia clearance 1

Monitoring During Treatment

  • Ammonia levels: Every 1-3 hours initially 1
  • Electrolytes: Frequent monitoring during dialysis 1
  • Neurological status: Continuous assessment
  • Consider transcranial Doppler if available to monitor cerebral blood flow 8

Common Pitfalls to Avoid

  1. Delaying dialysis while waiting for medical therapy to work - at 366 µmol/L, medical therapy alone is insufficient 1, 5
  2. Prolonged protein restriction beyond 48 hours without reintroduction - this drives catabolism and worsens hyperammonemia 1
  3. Inadequate dialysate flow rates - standard CKRT settings are insufficient; high-dose protocols are required 1, 7
  4. Stopping dialysis too early - wait for two consecutive hourly measurements <200 µmol/L 1, 4

Algorithm Summary

For ammonia 366 µmol/L:

  1. Immediate: Stop protein, start IV glucose/lipids, initiate nitrogen scavengers
  2. Within 1-2 hours: Establish vascular access and initiate high-dose CVVHD
  3. Target: Ammonia <200 µmol/L within 7-10 hours
  4. Transition: Step down to medical management only after sustained ammonia <200 µmol/L
  5. Recovery: Gradual protein reintroduction once ammonia 80-100 µmol/L

This aggressive combined approach is essential because your patient's ammonia level places them at immediate risk of irreversible brain injury, and the duration of exposure to this toxic level directly determines neurological outcome.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.